Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Oncotarget
|
March 20, 2018
ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells
Mengfan Qi, Ye Tian, Wang Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 7, 2023
SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1
Zifeng Wang, Jessica Petricca, Mingyu Liu, et al.
Nature Communications
|
December 14, 2025
Targeting of the m<sup>6</sup>A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer
Heming Zhou, Huarong Chen, Weixin Liu, et al.
Nature Cancer
|
February 6, 2026
METTL3-based epitranscriptomic editing screening identifies functional m<sup>6</sup>A sites in cancers
Xin Xu, Yujuan Wang, Helen Zhu, et al.
Cell
|
June 26, 2018
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng, Martin W LaFleur, Thao H Nguyen, et al.
BMC Cancer
|
June 18, 2024
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer
Xinpei Ci, Sujun Chen, Rui Zhu, et al.
Research Square
|
September 2, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer
Leigh Ellis, Beatriz German, Katherine Morel, et al.
Molecular Cell
|
July 21, 2023
A lncRNA from the FTO locus acts as a suppressor of the m<sup>6</sup>A writer complex and p53 tumor suppression signaling
Jianong Zhang, Jiangbo Wei, Rui Sun, et al.
Nature Communications
|
March 30, 2023
MYC reshapes CTCF-mediated chromatin architecture in prostate cancer
Zhao Wei, Song Wang, Yaning Xu, et al.
Nature Genetics
|
April 1, 2025
Spatially resolved transcriptomic analysis of the adult human prostate
Junyi Hu, Fei Liu, Jing Zhang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Oncotarget
|
March 20, 2018
ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells
Mengfan Qi, Ye Tian, Wang Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 7, 2023
SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1
Zifeng Wang, Jessica Petricca, Mingyu Liu, et al.
Nature Communications
|
December 14, 2025
Targeting of the m<sup>6</sup>A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer
Heming Zhou, Huarong Chen, Weixin Liu, et al.
Nature Cancer
|
February 6, 2026
METTL3-based epitranscriptomic editing screening identifies functional m<sup>6</sup>A sites in cancers
Xin Xu, Yujuan Wang, Helen Zhu, et al.
Cell
|
June 26, 2018
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng, Martin W LaFleur, Thao H Nguyen, et al.
BMC Cancer
|
June 18, 2024
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer
Xinpei Ci, Sujun Chen, Rui Zhu, et al.
Research Square
|
September 2, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer
Leigh Ellis, Beatriz German, Katherine Morel, et al.
Molecular Cell
|
July 21, 2023
A lncRNA from the FTO locus acts as a suppressor of the m<sup>6</sup>A writer complex and p53 tumor suppression signaling
Jianong Zhang, Jiangbo Wei, Rui Sun, et al.
Nature Communications
|
March 30, 2023
MYC reshapes CTCF-mediated chromatin architecture in prostate cancer
Zhao Wei, Song Wang, Yaning Xu, et al.
Nature Genetics
|
April 1, 2025
Spatially resolved transcriptomic analysis of the adult human prostate
Junyi Hu, Fei Liu, Jing Zhang, et al.
Page
of 6